Bleeding risk ends aspirin-clopidogrel trial

10/10/2011 | TheHeart.org (Montreal) (free registration)

The National Institute of Neurological Disorders and Stroke has halted the study of an aspirin-clopidogrel combination in the Secondary Prevention of Small Subcortical Strokes trial. Mortality rates and bleeding risk were higher for that combination, and an analysis showed little chance of benefit.

View Full Article in:

TheHeart.org (Montreal) (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID